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Cryptococcus neoformans is an opportunistic fungal pathogen that causes meningoencephalitis. Its cell wall
is composed of glucans, proteins, chitin, and chitosan. Multiple genetic approaches have defined a chitosan-
deficient syndrome that includes slow growth and decreased cell integrity. Here we demonstrate chitosan is
necessary for virulence and persistence in the mammalian host.
Cryptococcus neoformans is an opportunistic fungal patho-
gen that causes cryptococcosis in immunocompromised indi-
viduals. The incidence of cryptococcosis is rising in direct pro-
portion to the spread of human immunodeficiency virus (for
review see, Heitman et al. [10]). It is estimated that worldwide,
over 1 million people develop life-threatening cryptococcal
meningitis and that an estimated 700,000 die every year from
cryptococcosis (18). Current antifungal therapies for treatment
of cryptococcosis are inadequate: amphotericin B is effective,
but toxic; fluconazole is fungistatic, having high relapse rates;
flucytosine (5-FC) incurs frequent resistance (19–21, 25). Com-
ponents of the fungal cell wall are attractive antifungal drug
targets because they are absent in the host. The echinocandins,
for example, target -(1,3)-glucan synthase, an enzyme essen-
tial for the synthesis of a major component in the fungal cell
wall (13, 24). Echinocandins are well-tolerated by patients but
are not effective against C. neoformans (14).
The cell wall of C. neoformans is an essential organelle that
provides cellular structure and integrity. An indispensable com-
ponent of this cell wall that contributes to its strength and integ-
rity is chitin (1). Chitin is a linear polymer of -(1,4)-linked N-
acetylglucosamine (GlcNAc) synthesized by the chitin synthase/
regulator (Chs/Csr) system. Chitin can then be enzymatically
deacetylated to chitosan by chitin deacetylases (EC 3.5.1.41). The
cell wall of C. neoformans contains polymers of both chitin and
chitosan, and the quantity and ratio can be dynamic depending on
the growth phase (4, 5). In C. neoformans, only the isoforms Chs3
and Csr2 produce the majority of vegetative cell wall chitin, which
is converted to chitosan (despite there being eight chitin synthase
genes [CHS] and three synthase regulator genes [CSR]) (5). C.
neoformans also expresses three chitin deacetylases, Cda1, Cda2,
and Cda3, that can each produce chitosan. Strains of C. neofor-
mans deleted for CHS3, CSR2, or all three chitin deacetylases are
deficient in chitosan production and have a common set of phe-
notypes, including sensitivity to a variety of cell wall inhibitors.
This indicates that chitosan is essential for the proper mainte-
nance of cell wall integrity in C. neoformans, and Chs3, Csr2, and
the chitin deacetylases are the main proteins that contribute to its
formation (4, 5). Chitosan deficiency also affects two virulence
factors of C. neoformans, melanin and capsule. The chs3, csr2,
and cda1 cda2 cda3 strains “leak” melanin, and under certain
conditions their capsule is enlarged and less uniform (4, 5). These
three strains, chs3, csr2, and cda1 cda2 cda3, represent
three distinct deletions of proteins with different activities, which
independently lead to chitosan deficiency.
We hypothesized that chitosan would be an important struc-
tural component for C. neoformans growth in the mammalian
host, based on the impaired cell wall observed in chitosan-
deficient mutants in vitro. In this report we show that chitosan
is produced by Cryptococcus during murine infection and that
strains deficient in chitosan due to mutations in three distinct
genetic processes are avirulent and are rapidly cleared by the
mammalian host. For each of the chitosan-deficient lines, at
least two independently derived isolates were obtained and
tested. The data were similar for the two independently de-
rived isolates in all three lines; therefore, data shown here for
each chitosan-deficient strain were derived from one of the
isolates.
C. neoformans produces chitosan during in vivo growth. In
vitro analyses indicated that the cell wall integrity of strains that
produce little to no chitosan is compromised, but the strains
are still viable (4, 5). This suggests that chitosan is not essential
for in vitro growth; however, we postulated that the loss of cell
wall chitosan could impact the ability of C. neoformans to
survive within the host. To begin addressing this question, we
considered that if chitosan is important for growth in vivo, then
the celluar content of it would be similar to amounts measured
for cultures grown in vitro. Therefore, we first established
whether chitosan was produced by C. neoformans during
growth in the mammalian host. Mice were inoculated intrana-
sally with 106 wild-type (KN99) cells, and lungs from each
mouse were harvested 16 days postinfection (p.i.), homoge-
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nized in phosphate-buffered saline, and then extracted in 1 M
KOH at 80°C for 1.5 h. Deacetylation of chitin under the
conditions used for alkaline extraction was not detectable in
control experiments (data not shown). Pellets containing the
cryptococci were collected by centrifugation from each lung
extract along with small amounts of lung material. The pellets
were suspended in 1 ml 0.1 M KOH. A 10-l aliquot was
removed, stained with Solophenyl flavine (11) to facilitate
counting using a hemacytometer when viewed by fluorescence
microscopy (fluoroscein isothiocyanate filters). Each sample,
containing approximately 2  108 cryptococci, was divided in
two, and the chitosan in one half was converted to chitin by
acetylation with acetic anhydride and the other half remained
untreated. The chitin in both halves was measured, and the
chitosan amount was calculated as the difference between the
two measurements as previously described (4). The chitosan
and chitin data, normalized to the number of cryptococcus cells
from each sample, were found to be comparable to KN99
cultured in yeast extract-peptone-dextrose (YPD) at 30°C for 1
day and 3 days (Fig. 1). Chitin and chitosan were not detected
from uninfected lungs (data not shown). After 16 days in the
host lung, C. neoformans cell number increased by 200-fold
(about 8 doublings). Chitin and chitosan levels are dynamic
during growth in YPD (Fig. 1), so direct comparisons to any
specific in vitro condition are difficult (5). These data demon-
strated that chitosan was produced by C. neoformans during in
vivo growth and implied that it may be important during in-
fection of the mammalian host.
Strains with reduced chitosan grow slowly at 37oC. The
ability to grow at host temperature is a feature indicative of a
successful mammalian pathogen. Previous reports on the three
chitosan-deficient strains, chs3, csr2, and cda1 cda2
cda3, indicated that chs3 and csr2 are temperature sensi-
tive when grown in vitro and that cda1 cda2 cda3 is not (4,
5). However, these experiments were performed on solid me-
dia. The inability of the chs3 and csr2 strains to grow on a
plate may have indicated that the cells were dead or that they
had entered a state of stasis, in which they were still viable but
unable to divide. To distinguish between these two possibili-
ties, we investigated the growth rate of the chitosan-deficient
strains in liquid yeast nitrogen base with 2% glucose (YNB)
medium, pH 4, at either 30°C or 37°C. Strains deficient in
cellular chitosan, chs3, csr2, and cda1 cda2 cda3, grew
more slowly than the wild type at both temperatures and had a
greater growth defect at 37°C. They experienced a long lag
phase compared to the wild type, anywhere between 12 h and
24 h at both temperatures, before undergoing a doubling event
over the next 24-hour period (Fig. 2). These data demonstrate
that although the chitosan-deficient strains grow more slowly,
they are viable at 37°C and will grow at the mammalian host
temperature.
Lack of cellular chitosan attenuates virulence. A popular
hypothesis is that strains that grow slowly at host temperature
will be avirulent. However, Missall et al. observed that a strain
deleted for a thioredoxin, TRX1, that grows slowly at 37°C was
still virulent (15). We compared the growth rate of the trx1
mutant at both 30°C and 37°C in YNB and found that it was
very similar to what we observed with the three chitosan-
deficient strains (Fig. 2). These data suggest that slow growth
at 37°C does not necessarily predict avirulence and that testing
the chitosan-deficient strains for virulence might provide valu-
able insights.
Our initial hypothesis was that chitosan would be important for
virulence, based on the in vitro cell wall sensitivities of the defi-
cient strains and on the observation that wild-type C. neoformans
produces chitosan during infection. To determine if loss of cellu-
lar chitosan affects virulence, we used an inhalation mouse model
as previously described (8, 15) with the following exceptions; mice
(CBA/J; Jackson Laboratories) were inoculated with 1 105 cells
per strain tested and sacrificed when they reached 75% of their
original body weight. All mice inoculated with the wild-type strain
FIG. 1. Chitosan and chitin levels from KN99 recovered from
mouse lungs 16 days p.i. Chitosan and chitin levels from mouse lungs
were compared to levels measured for KN99 grown in YPD at 30°C for
1 day and 3 days from a starting optical density at 600 nm of 0.10. Error
bars indicate standard deviations for averaged measurements from
four mice, and five 1-day YPD and four 3-day YPD cultures.
FIG. 2. Growth curves of strains in liquid YNB at 30°C (A) or 37°C
(B). The inset of panel B shows csr2, chs3, cda1 cda2 cda3, and
trx1 strains on an expanded y axis. Strains are listed on the right side
of panel A. The x axis is in hours. Data consist of three bioreplicates,
each with two technical replicates, with standard errors shown.
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became ill and were sacrificed by 19 days p.i. None of the mice
infected with the chitosan-deficient strains showed loss of weight
or displayed symptoms of illness throughout the 60-day experi-
ment, supporting the hypothesis that chitosan was necessary for
virulence (Fig. 3). A second, independently generated mutant line
for each of the deletion strains was also tested in mice, with
identical results (data not shown). Taken together, these data
indicated that chitosan is necessary for the virulence of C. neo-
formans.
Chitosan-deficient strains are quickly eradicated from the
lungs. We sought to determine if the Cryptococcus strains were
avirulent, because they were more susceptible to killing and
clearance by the host. To test this, four mice were infected with
two independently generated strains of each mutation as de-
scribed above, and lung tissue harvested at 2 h, 8 h, 24 h, 48 h,
7 days, and 15 days p.i. For the determination of CFU, one
lung from each mouse was placed in 2.5 ml of 1 phosphate-
buffered solution (pH 7), homogenized, serially diluted, and
plated onto YPD supplemented with 100 g/ml streptomycin
and ampicillin. The second lung of each mouse was preserved
for histology preparation in 5 ml of 10% buffered formalin (see
below). We found that the fungal burden of the trx1 strain,
which grows slowly at 37°C, was similar to its wild-type (H99)
progenitor. Only at very early time points (2 to 24 h) were live
cells recovered from mice infected with chitosan-deficient
strains, and no CFU were recovered from tissue infected with
these strains past 24 h p.i. (Fig. 4A). These data demonstrated
FIG. 3. Virulence of chitosan-deficient strains. Strains are listed.
Data represent results for two independent isolates per deletion
strain.
FIG. 4. Fungal burden over time for selected strains. Data are from four mice per strain. Strains are listed to the right of each graph. nd, not
determined; a dash indicates no live cells were recovered. (A) *, significant difference between deletion strains and wild type at 2 h (chs3, P 
0.009; csr2, P  0.010; cda1 cda2 cda3, P  0.003); P  0.001 for the 8-h and 24-h time points based on one-way analysis of variance with
Dunnett’s post hoc test. Data represent one of two independent isolates for each chitosan-deficient strain after the 24-h time point. Standard errors
are shown. (B) Fungal burden of the complemented strain. Wild-type and cda2 cda3 controls were included.
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that chitosan is necessary for the viability of Cryptococcus
within the host and suggest that it is important for the estab-
lishment of a successful infection.
Chitosan-deficient strains are cleared faster than other
avirulent strains. Two well-established virulence factors of C.
neoformans are its abilities to produce a polysaccharide capsule
and the pigment melanin (7, 22). Both of these virulence fac-
tors are associated with the cell wall. The deletions cap59 (an
acapsular strain) and lac1 (a strain lacking melanin produc-
tion) each lead to the complete loss of virulence of C. neofor-
mans (7, 22). Given that the chitosan-deficient strains are also
avirulent, we sought to determine if their clearance patterns
were similar to the acapsular and melanin-deficient strains.
The fungal burdens of mice infected with the chitosan-defi-
cient strains were much lower than those of acapsular or mel-
anin-deficient strains, as only cap59 and lac1 cells were
recovered from infected tissue 48 h to 15 days p.i. (Fig. 4A).
These data indicate that the loss of chitosan renders Crypto-
coccus more susceptible to killing by the host than does the loss
of capsule or melanin.
Complementation of a chitosan-deficient strain restores
fungal burden to wild-type levels. To date, we have been un-
able to complement the chs3 and csr2 strains. Several at-
tempts were made to biolistically reintroduce a wild-type copy
of CHS3 or CSR2 into their respective deletion strains. In
addition to our normal transformation procedures, we tried
two modifications, including reduction in the pressure at which
the DNA-covered gold particles were delivered and inclusion
of sorbitol in the transformation recovery plates. Furthermore,
we tried to introduce the complementation DNA by using an
electroporation method both with and without sorbitol in the
recovery plates (9). No colonies were ever recovered from any
of these transformation attempts, while control strains gener-
ally produced hundreds of colonies. This indicated that the cell
walls of the chs3 and csr2 strains were compromised to a
point that they could not survive any of the transformation
procedures.
Interestingly, the cda1 cda2 cda3 strain was transform-
able, and we were able to complement it by integrating a
wild-type copy of CDA1 into the cda1 locus. The cda1 cda2
cda3 makes more chitin than either the chs3 or csr2 strain
(4), and this additional chitin may provide enough structural
integrity to the cell wall to permit transformation (4).
A cda2 cda3 strain, which still contains a wild-type copy
of CDA1 and makes near-wild-type levels of chitin and chi-
tosan (4), had a clearance pattern similar to the wild type and
was used as a positive control for the cda1::CDA1 cda2
cda3 strain. The fungal burden of cda1::CDA1 cda2 cda3
was similar to both cda2 cda3 and wild-type strains (Fig.
4B). These data suggest that the complete lack of chitosan is
necessary for the rapid killing of C. neoformans in the mam-
malian host.
The host readily cleared nonviable cells of chitosan-defi-
cient strains from lung tissue. Because the fungal burden assay
provides only live cell counts, we determined if the nonviable
cells were also being readily cleared from the host. Lung tissue
was harvested for histology as described above. Histology prep-
arations of stepwise, longitudinal lung sections stained with
Grocott’s methenamine silver (GMS) were made by the De-
partment of Pathology core facility at Washington University
School of Medicine (St. Louis, MO). We observed cells in all
samples up to 48 h p.i. (Fig. 5). The chitosan-deficient strains
showed decreased cell numbers after 8 h, suggesting that clear-
ance of the nonviable cells was occurring.
Chitosan is likely critical for virulence of C. neoformans. Our
results are consistent with and suggestive of the notion that
chitosan-deficient cell walls make fungal cells more vulnerable
to host defense mechanisms, and they indirectly suggest a role
for this cell wall component in virulence. The result that chi-
tosan-deficient mutants with genetic defects in three distinct
proteins were all avirulent and rapidly killed by the host lends
strength to the argument that chitosan deficiency was directly
responsible. It is possible that destabilization of the cell wall
due to lack of chitosan renders C. neoformans highly suscep-
tible to host killing and clearance (23). Alternatively, a lack of
chitosan could expose other pathogen-associated molecular
patterns (PAMPs) and increase the host response to the mu-
tant Cryptococcus. Finally, host chitinases are induced by C.
neoformans and other fungal pathogens, and converting chitin
to chitosan may be a mechanism to protect the fungus from
detrimental effects of chitinases.
Proteins that produce chitosan may be good antifungal drug
targets. This is the first report to demonstrate the importance
of cell wall chitosan for virulence of a human fungal pathogen.
Other opportunistic fungal pathogens have been reported to
produce chitosan. Aspergillus fumigatus produces chitosan in its
mycelia and conidia (16), while Mucor rouxii generates signif-
icant amounts of chitosan in the cell wall of structures found
throughout its life cycle (3, 6, 12, 17, 26). Additionally, a chitin
deacetylase gene was shown to be highly transcribed in the
yeast phase of Paracoccidioides brasiliensis (2). It has yet to be
determined if loss of chitosan will have the same effect on
other pathogenic fungi as it does on C. neoformans. Many
fungal pathogens produce chitosan in some phase of their life
cycles, but here chitosan has been shown to be essential for
cryptococcal virulence. We postulate that the proteins that
generate chitosan could prove to be excellent antifungal drug
targets.
FIG. 5. Average cryptoccocal cell numbers in longitudinal lung sec-
tions. Cryptoccocal cells in three stepwise lung sections from each
mouse were stained with Grocott’s methenamine silver (GMS). All
cells in lung sections were counted by viewing with a light microscope.
The number of cells for time points 8 to 48 h of each strain were
calculated as a percentage of cells counted for each respective 2-h time
point. Error bars indicate standard deviations between the four mice
(12 lung sections) in each group.
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